stock
NUVB · Nuvation Bio Inc.
What Nuvation Bio Inc. reports to the SEC, read from its filings.
Open in the appPrice
The live NUVB price and today's change.
Sign in to see thisChart
Thirty days of daily bars, with signal levels drawn on them.
Sign in to see thisSignals
The latest signal group Nakagai's scanner recorded on NUVB.
Sign in to see thisOptions positioning
Gamma exposure levels from the options market.
Sign in to see thisTechnicals
Trend, momentum and volatility gauges per timeframe.
Sign in to see thisWhat it is
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Filer (SEC EDGAR)
- EDGAR filing index
- Shares outstanding
- 351,123,233 as of 2026-08-03 (XBRL frame CY2026Q2I)
Key stats
Valuation
- P/E
- Locked
- P/S
- Locked
- P/B
- Locked
- Enterprise value
- Locked
- EV/EBIT
- Locked
- FCF yield
- Locked
Margins
- Gross
- —
- Operating
- -81.0%
- Net
- -88.2%
Returns
- ROE
- -59.0%
- ROA
- -20.1%
Health
- Current ratio
- 8.4x
- Debt/equity
- 1.0x
Deep value
- NCAV
- $235.79M
- NCAV per share
- $0.67
- Price/NCAV
- Locked
- NNWC
- -$222.08M
- NNWC per share
- -$0.63
- Price/NNWC
- Locked
Valuation and the price multiples are built on the live price. Trailing twelve months to 2026-06-30; balance sheet at 2026-06-30.
Sign in to see thisDebt is long-term debt and its current portion. Commercial paper and short-term borrowings are not counted.
Results
| Period end | Revenue | Gross profit | Operating income | Net income | Filing |
|---|---|---|---|---|---|
| 2026-06-30 | $31.69M | — | -$51.04M | -$62.84M | 10-Q filed 2026-08-06 |
| 2026-03-31 | $83.23M | — | $3.88M | $5.40M | 10-Q filed 2026-08-06 Assembled from more than one filing; the filing above is only the newest of them. |
| 2025-12-31 | $41.87M | — | -$34.04M | -$36.59M | DEF 14A filed 2026-04-10 Derived: the full year minus the first three quarters, not a figure this filer reported as a quarter. Assembled from more than one filing; the filing above is only the newest of them. |
| 2025-09-30 | $13.12M | $9.77M | -$56.43M | -$55.79M | 10-Q filed 2025-11-03 |
| 2025-06-30 | $4.83M | $2.26M | -$63.59M | -$59.01M | 10-Q filed 2026-08-06 Assembled from more than one filing; the filing above is only the newest of them. |
| 2025-03-31 | $3.08M | $990,000 | -$59.00M | -$53.24M | 10-Q filed 2026-08-06 Assembled from more than one filing; the filing above is only the newest of them. |
| 2024-12-31 | $5.71M | $1.50M | -$53.94M | -$49.45M | DEF 14A filed 2026-04-10 Derived: the full year minus the first three quarters, not a figure this filer reported as a quarter. Assembled from more than one filing; the filing above is only the newest of them. |
| 2024-09-30 | $727,000 | -$788,000 | -$48.10M | -$41.21M | 10-Q filed 2025-11-03 |
- Assets
- $744.50M
- Equity
- $253.86M
Balance as of 2026-06-30.
Ten years
| Fiscal year end | Revenue | Operating income | Net income | Free cash flow |
|---|---|---|---|---|
| 2025-12-31 | $62.90M | -$213.06M | -$204.63M | — |
| 2024-12-31 | $7.87M | -$592.63M | -$567.94M | — |
| 2023-12-31 | $0 | -$99.82M | -$75.80M | — |
| 2022-12-31 | — | -$119.73M | -$104.20M | — |
| 2021-12-31 | — | -$93.32M | -$86.85M | — |
| 2020-12-31 | — | -$43.55M | -$41.66M | — |
Company filings
2 offering filings in 12 months
Insiders, politicians and funds
Insider trades, last 90 days
Hattersley Gary
CHIEF SCIENTIFIC OFFICER
Sale$709,240Aug 21, 4:49 PM ET
Politician trades, last 90 days
No politician trades filed in the last 90 days.
Funds
- Duquesne Family Office
Period Tue 30 Jun 2026
0.5%Same
News
Stories that named NUVB, and the market events around them.
Sign in to see thisBoard
Recent signals
Signals open up here once a member has posted about NUVB.
Signals are informational.
Posts · 0
No posts yet.
nakagai
Signals on NUVB come from a rule, not a model.
Nakagai’s scanner records a signal the moment a strategy’s rule matches on the bars. Members read those signals on their own desk, where an agent journals the tape and briefs them in plain English.
Members post on the NUVB board